Atlas Trials

Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome

Clinical trial NCT01171378 · COMPLETED

Trial details

NCT number
NCT01171378
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Richter's Syndrome
Start date
2011-04-01
Primary completion
2015-02-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.